Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Thalidomide plus temozolomide in malignant gliomas

Dec. 5, 2002

Good tolerability profile reported for tetracycline COL-3 in high-grade glioma

Dec. 5, 2002

Mercury Therapeutics licenses oncology target from Mass General

Dec. 4, 2002

Axcan receives approvable letter for Photofrin

Dec. 4, 2002

Enrollment completed in phase III trial of ABI-007

Dec. 4, 2002

Taxotere approved for first-line therapy in NSCLC

Dec. 4, 2002

Human Genome Sciences and Kirin announce license agreement

Dec. 4, 2002

Corixa withdraws dispute resolution as FDA returns Bexxar to active review status

Dec. 4, 2002

Telomerase inhibitor with potential as an antitumor and radiosensitizing agent

Dec. 4, 2002

Sulfonyhydrazine prodrug VNP-40101M advances towards phase II clinical evaluation

Dec. 4, 2002

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...